Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas J Vogelzang

Showing results (1-10 of 287) with videos related to

Pageof 29
Sort By:
The New England Journal of Medicine|September 28, 2012
Enzalutamide--a major advance in the treatment of metastatic prostate cancerNicholas J Vogelzang
Thoracic Surgery Clinics|November 24, 2004
Multimodality therapy in mesothelioma: role of chemotherapyNicholas J Vogelzang
European Urology|October 3, 2018
Bladder Tumors with Mixed Histology: What Is the Basis for the Heterogeneity?Nicholas J Vogelzang
Clinical Lung Cancer|November 11, 2003
Re: a multicenter phase II study of gemcitabine and oxaliplatin for malignant pleural mesotheliomaNicholas J Vogelzang
Seminars in Oncology|February 7, 2003
Emerging insights into the biology and therapy of malignant mesotheliomaNicholas J Vogelzang
Oncology (Williston Park, N.Y.)|August 28, 2013
Two paths forward in metastatic castration-resistant prostate cancerNicholas J Vogelzang
JAMA Oncology|February 1, 2019
Adjuvant Androgen-Deprivation Therapy for Prostate Cancer: Should Docetaxel Be Added?Nicholas J Vogelzang
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2013
Antiangiogenic agents, chemotherapy, and the treatment of metastatic transitional cell carcinomaNicholas J Vogelzang
Lancet (London, England)|May 20, 2008
Chemotherapy for malignant pleural mesotheliomaNicholas J Vogelzang
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2010
Another step toward the cure of metastatic renal cell carcinoma?Nicholas J Vogelzang
Pageof 29

Showing results (1-10 of 287) with videos related to

Sort By:
Pageof 29
The New England Journal of Medicine|September 28, 2012
Enzalutamide--a major advance in the treatment of metastatic prostate cancerNicholas J Vogelzang
Thoracic Surgery Clinics|November 24, 2004
Multimodality therapy in mesothelioma: role of chemotherapyNicholas J Vogelzang
European Urology|October 3, 2018
Bladder Tumors with Mixed Histology: What Is the Basis for the Heterogeneity?Nicholas J Vogelzang
Clinical Lung Cancer|November 11, 2003
Re: a multicenter phase II study of gemcitabine and oxaliplatin for malignant pleural mesotheliomaNicholas J Vogelzang
Seminars in Oncology|February 7, 2003
Emerging insights into the biology and therapy of malignant mesotheliomaNicholas J Vogelzang
Oncology (Williston Park, N.Y.)|August 28, 2013
Two paths forward in metastatic castration-resistant prostate cancerNicholas J Vogelzang
JAMA Oncology|February 1, 2019
Adjuvant Androgen-Deprivation Therapy for Prostate Cancer: Should Docetaxel Be Added?Nicholas J Vogelzang
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2013
Antiangiogenic agents, chemotherapy, and the treatment of metastatic transitional cell carcinomaNicholas J Vogelzang
Lancet (London, England)|May 20, 2008
Chemotherapy for malignant pleural mesotheliomaNicholas J Vogelzang
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2010
Another step toward the cure of metastatic renal cell carcinoma?Nicholas J Vogelzang
Pageof 29